GlassScriptPhysician profile
David L Eisenberg
NPI 1033304415
$11,291.03
in general payments reported to CMS, 2019-2025
13 companies · $23.26 in 2025
The $23.26 reported for 2025 was less than what a typical Gynecology provider received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,443 · 2020: $765 · 2021: $4,680 · 2022: $180 · 2023: $175 · 2024: $3,024 · 2025: $23.26.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $2,886 · Food and Beverage: $337.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $2,886.00 |
| Food and Beverage | $336.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evofem Biosciences, INC. | $4,675.00 | 2021 | |
| Organon LLC | $3,313.84 | 2022-2025 | Nexplanon |
| Merck Sharp & Dohme LLC | $1,596.07 | 2019-2021 | |
| Medicines360 | $1,500.00 | 2019-2020 | |
| Abbvie INC. | $70.91 | 2019-2020 | |
| Meditrina | $32.89 | 2022 | |
| Astellas Pharma US INC | $24.15 | 2024 | Veozah |
| Therapeuticsmd, INC. | $17.81 | 2019 | |
| Applied Medical Resources Corporation | $16.27 | 2023 | |
| Covidien LP | $15.26 | 2019 | |
| Sumitomo Pharma America, INC. | $15.12 | 2023 | Myfembree |
| Exeltis, USA INC. | $13.71 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Eisenberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.